Regadenoson
NDC 71288-201, Regadenoson, injection, solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-201
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212806
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-201-85 | 71288020185 | 1 SYRINGE, PLASTIC in 1 CARTON (71288-201-85) / 5 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/a550b451-fb30-4c1c-a60e-6e40fba20c88Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71288-201
Use it
Look up 71288-201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.